Leslie Teso-Lichtman - 27 Jun 2022 Form 4 Insider Report for CHEMBIO DIAGNOSTICS, INC.

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CEMI	Restricted stock units	Award	$0	+64,000		$0.000000	64,000	27 Jun 2022	Common stock	64,000		Direct	F1, F2, F3
transaction	CEMI	Nonqualified stock options	Award	$0	+82,286		$0.000000	82,286	27 Jun 2022	Common stock	82,286	$1.25	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Awards were granted in connection with the initial election of the reporting person to the board of directors of the issuer, which occurred at the issuer's 2022 annual meeting of stockholders on May 24, 2022. The grants of the awards were deferred until a sufficient number of reserved shares of common stock had become available for grant under the 2019 Omnibus Incentive Plan of the issuer.
F2	Each restricted stock unit represents a contingent right to receive one share of common stock.
F3	The restricted stock units are scheduled to vest in three equal installments immediately prior to the 2023, 2024 and 2025 annual meetings of stockholders of the issuer, or shall vest in full upon a Change in Control (as defined in the 2019 Omnibus Incentive Plan of the issuer).
F4	The nonqualified stock options are scheduled to vest and become exercisable in full immediately prior to the earlier to occur of (i) the 2023 annual meeting of stockholders of the issuer and (ii) a Change in Control.